beta-lactams has been researched along with rifampin in 35 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 20,468 | 1,499 | 6,552 |
Protein | Taxonomy | beta-lactams (IC50) | rifampin (IC50) |
---|---|---|---|
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
Caspase-1 | Homo sapiens (human) | 8.319 | |
Alpha-synuclein | Homo sapiens (human) | 7.1 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.57) | 18.7374 |
1990's | 2 (5.71) | 18.2507 |
2000's | 10 (28.57) | 29.6817 |
2010's | 18 (51.43) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Moosdeen, F; Raimondi, A; Williams, JD | 1 |
Damme, J; Dieckman, E; Winslow, DL | 1 |
Garau, J; Liñares, J; Martín, R; Murgui, L; Perez, JL | 1 |
Cabellos, C; Liñares, J; Tuban, F | 1 |
Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M | 1 |
Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F | 1 |
Hughes, D; Macvanin, M | 1 |
Farny, K; Michault, A; Picot, S; Simac, C | 1 |
Tsuji, A | 1 |
Hassoun, A | 1 |
Chitnis, DS; Chitnis, S; Chitnis, V | 1 |
Abidi, MH; Chandrasekar, PH; Cronin, SM; Ibrahim, RB; Shearer, CJ | 1 |
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
Baddour, LM; Fadel, HJ; Steckelberg, JM; Tleyjeh, IM; Wilson, WR | 1 |
Bruun, T; Kittang, BR; Lund-Johansen, M; Mylvaganam, H; Skrede, S | 1 |
Brandão, AP; Brandileone, MC; de Paiva, MV; Gorla, MC; Lemos, AP; Salgueiro, VC; Vázquez, JA | 1 |
Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
Casini, B; Ferranti, S; Flammini, S; Giani, T; Leonildi, A; Lewis, R; Menichetti, F; Rossolini, GM; Tagliaferri, E; Tascini, C | 1 |
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
Aridogan, BC; Cetin, ES; Ozseven, AG; Tekeli, A; Us, E | 1 |
Cabellos, C; Force, E; Garrigós, C; Pachón-Ibañez, ME; Taberner, F | 1 |
Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A | 1 |
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U | 1 |
Bettoli, V; Join-Lambert, O; Nassif, A | 1 |
Davies, HA; Garamus, VM; Gorniak, T; Hilpert, K; Mikut, R; Reischl, M; Rosenhahn, A; von Gundlach, AR | 1 |
Caio, C; Gona, F; Mezzatesta, ML; Salerno, I; Stefani, S; Zingali, T | 1 |
de Moura, VC; Jackson, M; Jones, V; Li, W; North, EJ; Sanchez-Hidalgo, A | 1 |
Gurumurthy, M; Hee, KH; Issac, S; Lee, LS; Lin, W; Lu, Q; Naftalin, CM; Paton, NI; Seng, KY; Tan, A; Tan, KH; Verma, R | 1 |
Aboltins, CA; Ansart, S; Ariza, J; Arvieux, C; Asseray, N; Bahamonde, A; Baraia-Etxaburu, JM; Barbero, JM; Benito, N; Bernard, L; Choong, PFM; Clark, BM; Clauss, M; Cobo, J; Dapunt, U; Davis, JS; Del Toro, MD; Dupon, M; Esteban, J; Fernández-Sampedro, M; Ferrari, M; Ferry, T; Giannitsioti, E; Gómez, L; Gottlieb, T; Guío, L; Horcajada, JP; Huotari, K; Iribarren, JA; Jover-Sáenz, A; Juan, RS; Li, HK; Lora-Tamayo, J; Miksic, NG; Moal, GL; Neut, D; O'Connell, K; Pais, MJG; Palomino, J; Peel, TN; Ramos, A; Ribera, A; Rico, A; Riera, M; Rodríguez-Pardo, D; Salles, MJC; Sánchez-Somolinos, M; Sendi, P; Senneville, É; Skaliczki, G; Soriano, A; Trebše, R; Uçkay, I; Vigante, D; Zeller, V; Zimmerli, W | 1 |
Baud, D; Greub, G; Vouga, M | 1 |
Fredborg, M; Sondergaard, TE; Wang, M | 1 |
Bootsma, HJ; Cobbaert, CM; de Vries, JJC; Groeneveld, GH; Joosten, SA; Kuijper, EJ; van der Reyden, TJ; van Dissel, JT | 1 |
Helmann, JD; Patel, Y; Rhee, KY; Soni, V | 1 |
Hackemann, VCJ; Hagel, S; Jandt, KD; Löffler, B; Rödel, J; Tuchscherr, L | 1 |
3 review(s) available for beta-lactams and rifampin
Article | Year |
---|---|
Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy.
Topics: Animals; Anti-Infective Agents; beta-Lactams; Biological Transport; Drug Interactions; Humans; Intestinal Absorption; Membrane Transport Proteins; Quinolones; Rifampin; Tissue Distribution | 2006 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Antibiotic Treatment of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin | 2016 |
2 trial(s) available for beta-lactams and rifampin
Article | Year |
---|---|
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Drug Synergism; Female; Healthy Volunteers; Humans; Male; Mycobacterium tuberculosis; Rifampin; Serum Bactericidal Test; Young Adult | 2017 |
Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Netherlands; Plasma; Pneumonia, Pneumococcal; Rifampin; Teichoic Acids; Treatment Outcome; Young Adult | 2019 |
30 other study(ies) available for beta-lactams and rifampin
Article | Year |
---|---|
Antibiotic resistance pattern of Flavobacterium meningosepticum.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Flavobacterium; Humans; Infant, Newborn; Isoelectric Focusing; Rifampin; Tetracycline; Vancomycin | 1986 |
Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin.
Topics: Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Drug Interactions; Humans; Listeria monocytogenes; Meningitis, Listeria; Microbial Sensitivity Tests; Rifampin | 1983 |
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Carrier State; Child; Drug Combinations; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; beta-Lactams; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enzyme Inhibitors; Female; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin | 1999 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin | 2004 |
Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Mutation; Rifampin; Salmonella typhimurium; Ultraviolet Rays | 2005 |
[Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004].
Topics: Aza Compounds; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Ketolides; Moxifloxacin; Penicillin Resistance; Quinolines; Retrospective Studies; Reunion; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Treatment of Staphylococcus aureus prosthetic valve endocarditis.
Topics: Aminoglycosides; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
In vitro synergistic activity of colistin with aminoglycosides, beta-lactams and rifampin against multidrug-resistant gram-negative bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cells, Cultured; Colistin; Drug Combinations; Drug Synergism; Gram-Negative Bacteria; Humans; Rifampin | 2007 |
Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Actinomycetales Infections; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases; Male; Middle Aged; Radiography; Rhodococcus equi; Rifampin; Transplantation, Homologous | 2008 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Retrospective Studies; Rifampin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Clinical, microbiological and molecular characteristics of six cases of group A streptococcal meningitis in western Norway.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; beta-Lactams; Carrier Proteins; Child; Female; Gene Deletion; Humans; Male; Mastoiditis; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Norway; Rifampin; Streptococcal Infections; Streptococcus pyogenes; Superantigens | 2010 |
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Brazil; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Rifampin; Serotyping; Species Specificity; Young Adult | 2011 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Genes, Bacterial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microbial Viability; Rifampin | 2013 |
Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Polymyxin B; Rifampin | 2013 |
Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Topics: Acetamides; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycopeptides; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance | 2015 |
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins | 2015 |
Small angle X-ray scattering as a high-throughput method to classify antimicrobial modes of action.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Chloramphenicol; Ciprofloxacin; Drug Discovery; Escherichia coli K12; High-Throughput Screening Assays; Microscopy, Electron, Transmission; Polymyxin B; Principal Component Analysis; Rifampin; Scattering, Small Angle; Tetracycline; X-Ray Diffraction | 2016 |
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method.
Topics: Anti-Bacterial Agents; beta-Lactams; Colistin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Predictive Value of Tests; Rifampin; Thienamycins; Tigecycline | 2016 |
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds
Topics: Antitubercular Agents; beta-Lactams; Clofazimine; Diarylquinolines; Drug Synergism; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Rifampin | 2017 |
The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactams; Biofilms; Debridement; Female; Humans; Internationality; Male; Prognosis; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Salvage Therapy; Streptococcal Infections; Streptococcus agalactiae; Treatment Failure | 2017 |
Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Chlamydiaceae Infections; Chlamydiales; Chlorocebus aethiops; Clindamycin; Macrolides; Microbial Sensitivity Tests; Quinolones; Rifampin; Vancomycin; Vero Cells | 2017 |
Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Drug Synergism; Ertapenem; Humans; Meropenem; Polymyxins; Rifampin; Thienamycins | 2017 |
Mutations in
Topics: Acetylglucosamine; Antitubercular Agents; Bacterial Proteins; beta-Lactams; Cefuroxime; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Peptidoglycan; Rifampin; Uridine Diphosphate | 2023 |
The Controversial Effect of Antibiotics on Methicillin-Sensitive
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biofilms; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2023 |